KuiperCompagnons will design a new future proof laboratory facility for the pharmaceutical group Bilthoven Biologicals (BBIO) in Utrecht.

The Irish engineering and project management company DPS Group has linked with KuiperCompagnons and Kropman Contamination Control to design and construct a new future proof laboratory facility for the pharmaceutical group Bilthoven Biologicals (BBIO) in Utrecht, Netherlands. The new facility will be to GMP, Biosafety Level 3 (BSL3) and GAPIII compliant.

The project marks an important step in Bilthoven Biologics’ strategy to develop affordable vaccines for the world infant population.